Mizuho analyst Anthony Petrone lowered the firm’s price target on LivaNova (LIVN) to $60 from $70 and keeps an Outperform rating on the shares. The company reported a “mixed” Q4 with initial guidance coming in a touch light on sales due to a slowdown in epilepsy, the analyst tells investors in a research note. However, the firm sees an attractive setup for the shares in 2025.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LIVN:
- LivaNova price target lowered to $60 from $72 at Stifel
- LivaNova price target lowered to $60 from $72 at Baird
- LivaNova downgraded to Peer Perform from Outperform at Wolfe Research
- LivaNova PLC Reports Strong 2024 Financial Performance
- LivaNova’s Growth Potential Amid Challenges: Buy Rating Reaffirmed by Analyst